Lockdown as the mother of invention: disruptive technology in a disrupted time

Abstract

Comprehensive care for people with interstitial lung disease (ILD) requires careful monitoring and attention to detail. Many of the details that are important to inform best care in ILDs can now be monitored outside the clinic, thanks to advances in technology. Such monitoring includes remote measurement of lung function, monitoring of symptoms and treatment side-effects, and documentation of important health behaviours (such as medication adherence and physical activity). Marlies Wijsenbeek and colleagues provide a comprehensive overview of how these technologies have been applied in the care of people with ILD,1 a topic of relevance to both research and clinical practice.